• Home
• Media Outreach
• Jacobson Pharma Issues Positive Profit Alert

Kamis, 02 Mei 2019 20:30:00

Jacobson Pharma Issues Positive Profit Alert

Expects to Record Over 20% Increase in Profit Attributable to Shareholders

HONG KONG, CHINA - Media OutReach - 2 May 2019 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the  "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced a positive profit alert. Based on a preliminary review on the unaudited consolidated management accounts of the Group for the financial year ended 31 March 2019, the Group is expected to record an increase of over 20% in the consolidated profit attributable to shareholders of the Company as compared with that for the financial year ended 31 March 2018.

The encouraging results were mainly attributable to a steady growth of generic drug business along with the sales revenue generated from newly in-licensed products coupled with an uplifted sales performance on proprietary medicines. Operating leverages and financial savings derived from cost control measures, as well as fair value gain on investment properties of the Group are also expected to contribute to the above-mentioned increase.

Embedding the strategies of regional expansion and targeted portfolio enhancement through in-licensing or products developed in-house, Jacobson Pharma aims to become a leading generic drug and proprietary medicine company in Asia by building a commercially competitive platform in the region.

Backed by a vertically-integrated supply chain and its efficient production facilities as well as a robust in-house research and development pipeline, the Group is among the few with the most extensive sales and distribution coverage in both the private and public sectors in Hong Kong and is poised for a broadened geographic footprint.

Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, said, "The expected increase in earnings of the Company reflects the effectiveness of our across-the-board efforts and demonstrates our capabilities to execute on our growth strategies. From expanding our product portfolios to optimizing the  operating leverage across our production facilities as well as  implementing effective cost controls, our holistic and prudent approach is aimed at facilitating the Group's long-term growth and creating value for our shareholders."

7 hari lalu

Temukan Daftar BCCoin (BlackCardCoin) di XT

Dari perdagangan berjangka kripto hingga copy trading dan Futures Grid, XT terus berinovasi untuk memenuhi kebutuhan basis penggunanya yang terus berkembang.

7 hari lalu

ECOVACS ROBOTICS Bekerja Sama dengan Brand Ambassador Baru, Superstar Korea Selatan Jun Ji-hyun, untuk Perjalanan yang Dinamis ke Depan

Dengan penampilannya yang luar biasa, Jun Ji-hyun telah mendapatkan pujian kritis dan berbagai penghargaan. Selain itu, karisma, kepercayaan diri, dan keasliannya terus memikat hat

7 hari lalu

Platform Intelijen Fintech TwentyFold Money20/20 Memulai Debutnya di Asia di Money20/20 Asia

Hampir 15.000 startup fintech Asia dan hampir 5.500 investor yang berbasis di Asia terdaftar di Twentyfold, memenuhi kebutuhan pasar investasi startup yang ekspansif di Asia.

7 hari lalu

AIA Singapura memperkenalkan strategi kekayaan dan rencana ambisius untuk menjadi perusahaan asuransi terkemuka di segmen kekayaan

masing-masing merupakan tempat kolaborasi, memancarkan keanggunan modern sambil mengedepankan tujuan dan fokus. Semua karya seni di AIA Wealth Center menandakan "Kesejahteraan" mel